Michael E. Yeager

3.7k total citations
40 papers, 2.7k citations indexed

About

Michael E. Yeager is a scholar working on Pulmonary and Respiratory Medicine, Cardiology and Cardiovascular Medicine and Oncology. According to data from OpenAlex, Michael E. Yeager has authored 40 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Pulmonary and Respiratory Medicine, 9 papers in Cardiology and Cardiovascular Medicine and 7 papers in Oncology. Recurrent topics in Michael E. Yeager's work include Pulmonary Hypertension Research and Treatments (26 papers), Neonatal Respiratory Health Research (8 papers) and Medical Imaging and Pathology Studies (4 papers). Michael E. Yeager is often cited by papers focused on Pulmonary Hypertension Research and Treatments (26 papers), Neonatal Respiratory Health Research (8 papers) and Medical Imaging and Pathology Studies (4 papers). Michael E. Yeager collaborates with scholars based in United States, Germany and United Kingdom. Michael E. Yeager's co-authors include Kurt R. Stenmark, Rubin M. Tuder, Norbert F. Voelkel, Kelley L. Colvin, Maria G. Frid, Heiko Golpon, Carlyne D. Cool, Karim C. El Kasmi, Mark W. Geraci and Suzette Riddle and has published in prestigious journals such as New England Journal of Medicine, The Journal of Immunology and Circulation Research.

In The Last Decade

Michael E. Yeager

40 papers receiving 2.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Michael E. Yeager United States	25	1.7k	908	681	407	366	40	2.7k
Ari Zaiman United States	30	1.9k 1.1×	993 1.1×	1.0k 1.5×	379 0.9×	257 0.7×	41	3.4k
Edda Spiekerkoetter United States	28	2.2k 1.3×	660 0.7×	1.1k 1.7×	455 1.1×	247 0.7×	75	2.9k
Mark Southwood United Kingdom	33	2.7k 1.6×	1.3k 1.5×	868 1.3×	618 1.5×	727 2.0×	72	4.2k
Mark L. Ormiston Canada	23	1.3k 0.8×	940 1.0×	484 0.7×	298 0.7×	367 1.0×	39	2.3k
Mark Toshner United Kingdom	28	2.1k 1.2×	572 0.6×	1.1k 1.6×	260 0.6×	214 0.6×	95	3.0k
Vivian de Waard Netherlands	32	1.1k 0.6×	873 1.0×	751 1.1×	509 1.3×	306 0.8×	91	3.3k
Yupu Deng Canada	20	1.4k 0.8×	693 0.8×	382 0.6×	521 1.3×	270 0.7×	37	2.3k
Alexander Schmeißer Germany	27	487 0.3×	847 0.9×	865 1.3×	448 1.1×	295 0.8×	94	2.5k
Neal X. Chen United States	32	675 0.4×	1.2k 1.3×	414 0.6×	597 1.5×	258 0.7×	74	4.8k
Jun Mimuro Japan	29	583 0.3×	840 0.9×	339 0.5×	222 0.5×	655 1.8×	113	3.2k

Countries citing papers authored by Michael E. Yeager

Since Specialization

Citations

This map shows the geographic impact of Michael E. Yeager's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael E. Yeager with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael E. Yeager more than expected).

Fields of papers citing papers by Michael E. Yeager

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael E. Yeager. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael E. Yeager. The network helps show where Michael E. Yeager may publish in the future.

Co-authorship network of co-authors of Michael E. Yeager

This figure shows the co-authorship network connecting the top 25 collaborators of Michael E. Yeager. A scholar is included among the top collaborators of Michael E. Yeager based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael E. Yeager. Michael E. Yeager is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Colvin, Kelley L., et al.. (2023). Increased lethality of respiratory infection by Streptococcus pneumoniae in the Dp16 mouse model of Down syndrome. FASEB BioAdvances. 5(12). 528–540. 1 indexed citations

Schäfer, Michal, Alex J. Barker, Vitaly O. Kheyfets, et al.. (2017). Helicity and Vorticity of Pulmonary Arterial Flow in Patients With Pulmonary Hypertension: Quantitative Analysis of Flow Formations. Journal of the American Heart Association. 6(12). 53 indexed citations

Williams, Sarah, Lucy Golden‐Mason, Bradley S. Ferguson, et al.. (2014). Class I HDACs regulate angiotensin II-dependent cardiac fibrosis via fibroblasts and circulating fibrocytes. Journal of Molecular and Cellular Cardiology. 67. 112–125. 145 indexed citations

Colvin, Kelley L. & Michael E. Yeager. (2014). Proteomics of pulmonary hypertension: Could personalized profiles lead to personalized medicine?. PROTEOMICS - CLINICAL APPLICATIONS. 9(1-2). 111–120. 11 indexed citations

Colvin, Kelley L., et al.. (2013). Bronchus-associated Lymphoid Tissue in Pulmonary Hypertension Produces Pathologic Autoantibodies. American Journal of Respiratory and Critical Care Medicine. 188(9). 1126–1136. 63 indexed citations

Colvin, Kelley L., Kurt R. Stenmark, & Michael E. Yeager. (2013). Right ventricular lymphatic insufficiency is associated with increased edema in pulmonary hypertension. European Respiratory Journal. 42(Suppl 57). 1499–1499. 1 indexed citations

Villegas, Leah R., Dylan Kluck, Rebecca E. Oberley‐Deegan, et al.. (2012). Superoxide Dismutase Mimetic, MnTE-2-PyP, Attenuates Chronic Hypoxia-Induced Pulmonary Hypertension, Pulmonary Vascular Remodeling, and Activation of the NALP3 Inflammasome. Antioxidants and Redox Signaling. 18(14). 1753–1764. 70 indexed citations

Cavasin, Maria A., Todd R. Horn, Lori A. Walker, et al.. (2012). Selective Class I Histone Deacetylase Inhibition Suppresses Hypoxia-Induced Cardiopulmonary Remodeling Through an Antiproliferative Mechanism. Circulation Research. 110(5). 739–748. 140 indexed citations

Yeager, Michael E., et al.. (2012). Activation of the Unfolded Protein Response is Associated with Pulmonary Hypertension. Pulmonary Circulation. 2(2). 229–240. 40 indexed citations

10.

Yeager, Michael E., et al.. (2012). Loss Of Tolerance Associated With Bronchus Associated Lymphoid Tissue Expansion In Pulmonary Hypertension. A4761–A4761. 1 indexed citations

11.

Yeager, Michael E., Dmitry Belchenko, Kelley L. Colvin, et al.. (2011). Circulating fibrocytes are increased in children and young adults with pulmonary hypertension. European Respiratory Journal. 39(1). 104–111. 45 indexed citations

12.

Li, Min, Suzette Riddle, Maria G. Frid, et al.. (2011). Emergence of Fibroblasts with a Proinflammatory Epigenetically Altered Phenotype in Severe Hypoxic Pulmonary Hypertension. The Journal of Immunology. 187(5). 2711–2722. 182 indexed citations

13.

Yeager, Michael E., et al.. (2011). Endothelin-1, the Unfolded Protein Response, and Persistent Inflammation. American Journal of Respiratory Cell and Molecular Biology. 46(1). 14–22. 69 indexed citations

14.

Yeager, Michael E., Dmitry Belchenko, Kelley L. Colvin, et al.. (2011). Circulating Myeloid-Derived Suppressor Cells Are Increased and Activated in Pulmonary Hypertension. CHEST Journal. 141(4). 944–952. 37 indexed citations

15.

Yeager, Michael E., Maria G. Frid, & Kurt R. Stenmark. (2011). Progenitor Cells in Pulmonary Vascular Remodeling. Pulmonary Circulation. 1(1). 3–16. 62 indexed citations

16.

Richter, Amy, Michael E. Yeager, Ari Zaiman, et al.. (2004). Impaired Transforming Growth Factor-β Signaling in Idiopathic Pulmonary Arterial Hypertension. American Journal of Respiratory and Critical Care Medicine. 170(12). 1340–1348. 108 indexed citations

17.

Voelkel, Norbert F., Carlyne D. Cool, Mark W. Geraci, et al.. (2002). Janus face of vascular endothelial growth factor: The obligatory survival factor for lung vascular endothelium controls precapillary artery remodeling in severe pulmonary hypertension. Critical Care Medicine. 30(Supplement). S251–S256. 75 indexed citations

18.

Geraci, Mark W., Yasushi Hoshikawa, Michael E. Yeager, et al.. (2002). Gene Expression Profiles in Pulmonary Hypertension. CHEST Journal. 121(3). 104S–105S. 4 indexed citations

19.

Tuder, Rubin M., Michael E. Yeager, Mark W. Geraci, Heiko Golpon, & N. F. Voelkel. (2001). Severe pulmonary hypertension after the discovery of the familial primary pulmonary hypertension gene. European Respiratory Journal. 17(6). 1065–1069. 27 indexed citations

20.

Tuder, Rubin M., et al.. (2001). THE PATHOBIOLOGY OF PULMONARY HYPERTENSION. Clinics in Chest Medicine. 22(3). 405–418. 147 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact